Number of items: 8.
2024
Pennel, K. A.F. et al.
(2024)
JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors.
Journal of Experimental and Clinical Cancer Research, 43,
64.
(doi: 10.1186/s13046-024-02958-4)
2023
Haddad, T. S. et al.
(2023)
Pseudobudding: ruptured glands do not represent true tumor buds.
Journal of Pathology, 261(1),
pp. 19-27.
(doi: 10.1002/path.6146)
(PMID:37403270)
Sykes, R. A. et al.
(2023)
Vascular mechanisms of post-COVID-19 conditions: rho-kinase is a novel target for therapy.
European Heart Journal: Cardiovascular Pharmacotherapy, 9(4),
pp. 371-386.
(doi: 10.1093/ehjcvp/pvad025)
(PMID:37019821)
(PMCID:PMC10236521)
Wood, C. S. et al.
(2023)
Spatially resolved transcriptomics deconvolutes prognostic histological subgroups in patients with colorectal cancer and synchronous liver metastases.
Cancer Research, 83(8),
pp. 1329-1344.
(doi: 10.1158/0008-5472.CAN-22-2794)
(PMID:37057593)
(PMCID:PMC10102851)
2022
Fisher, N. C. et al.
(2022)
Biological misinterpretation of transcriptional signatures in tumour samples can unknowingly undermine mechanistic understanding and faithful alignment with preclinical data.
Clinical Cancer Research, 28(18),
pp. 4056-4069.
(doi: 10.1158/1078-0432.CCR-22-1102)
(PMID:35792866)
(PMCID:PMC9475248)
Nassar, A., El Zanati, H., Ng, H. J., Khan, K. S. and Wood, C.
(2022)
Open conversion in laparoscopic cholecystectomy and bile duct exploration: subspecialisation safely reduces the conversion rates.
Surgical Endoscopy, 36(1),
pp. 550-558.
(doi: 10.1007/s00464-021-08316-1)
(PMID:33528666)
(PMCID:PMC8741693)
2021
Nassar, A. H.M., Ng, A. J., Ahmed, Z., Wysocki, A. P., Wood, C. and Abdellatif, A.
(2021)
Optimising the outcomes of index admission laparoscopic cholecystectomy and bile duct exploration for biliary emergencies: a service model.
Surgical Endoscopy, 35(8),
pp. 4192-4199.
(doi: 10.1007/s00464-020-07900-1)
(PMID:32860135)
Galbraith, N. J. , Wood, C. and Steele, C. W.
(2021)
Targeting metastatic colorectal cancer with immune oncological therapies.
Cancers, 13(14),
3566.
(doi: 10.3390/cancers13143566)
(PMID:34298779)
(PMCID:PMC8307556)
This list was generated on Mon Oct 14 04:10:49 2024 BST.